Revolutionizing early detection of oral cancer
Innovative methodology. Proven accuracy.*
BeVigilantTM OraFusion System
The first and only point-of-care test to aid clinicians in the early detection of oral cancer
Peace of Mind
Sense of Urgency
Join us in our fight to transform early oral cancer detection
Granted FDA Breakthrough Device Designation
The BeVigilantTM OraFusion System is Not Available For Sale in the U.S.
We relentlessly pursue life-changing answers to be the leading innovator and developer of solutions that aid clinicians in improving potential outcomes through earlier detection of oral cancer.
Resources for Clinicians
Explore white papers and other resources for dentists and other providers navigating the challenges surrounding oral cancer diagnosis and treatment.
Resources for Patients
Patient education and awareness is a key part of improving oral cancer outcomes. Access patient resources to learn more:
New & Noteworthy
Explore our latest blog posts and press releases
*Clinical Data on File